# data[].attributes.headline
  Mystery
  of Late-Stage Prostate Cancer Cells

# data[].attributes.subject
  Mystery
  of Late-Stage Prostate Cancer Cells

# data[].attributes.body
Researchers at the University of California, Santa Cruz, Findings may pave the way for a better understanding of the nature of later stage prostate cancers. This, in turn, could open doors for better treatments down the road.

# data[].attributes.attachment_link.readable_text
While most of the 220,000 American males diagnosed with prostate cancer this year will find their disease is in an earlier, more treatable stage, some will not. Aggressive forms of the disease, those that are later in stage and may have already spread to other parts of the body, pose a unique challenge in fighting. Researchers at the University of California, Santa Cruz, have been delving in to find out why. Their findings may pave the way for a better understanding of the nature of later stage prostate cancers. This, in turn, could open doors for better treatments down the road.

Early stage prostate cancer is oftentimes very slow growing and many present men with the option of simply living with it and monitoring activity. Those diagnosed with more aggressive forms of the disease will find that is not the case for them. This more aggressive prostate cancer is known to resist standard courses of treatment and has perplexed doctors thus far.

The UC Santa Cruz researchers believe they may have uncovered just why this form of the disease is so persistent. It seems the cells found in metastasized prostate cancer patients have properties that are very similar to actual stem cells. To reveal that finding, researchers analyzed biopsies from men living with the disease at present. They found the signature between prostate stem cells and the aggressive prostate cancer was quite similar. While far from a cure just yet, the new research provides valuable insight into the nature of aggressive prostate cancer. It serves as a springboard for future studies to develop treatments that might prove more beneficial for those in later stages of the disease.

Early detection and treatment of prostate cancer is generally considered critical. While researchers strive for better treatments for advanced cases, men can help themselves by going in for routine exams. Men should begin talking to their healthcare providers about prostate health in their 40s or so.

# data[].attributes.attachment_link.title
Researchers Unlocking the Mystery of Late-Stage Prostate Cancer Cells

# data[].attributes.attachment_link.description
While most of the 220,000 American males diagnosed with prostate cancer this year will find their disease is in an earlier, more treatable stage, some will not. Aggressive forms of the disease, those that are later in stage and may have already spread to other parts of the body, pose a unique challenge in fighting.

# data[].attributes.attachment_link.readable_text
While most of the 220,000 American males diagnosed with prostate cancer this year will find their disease is in an earlier, more treatable stage, some will not. Aggressive forms of the disease, those that are later in stage and may have already spread to other parts of the body, pose a unique challenge in fighting. Researchers at the University of California, Santa Cruz, have been delving in to find out why. Their findings may pave the way for a better understanding of the nature of later stage prostate cancers. This, in turn, could open doors for better treatments down the road.

Early stage prostate cancer is oftentimes very slow growing and many present men with the option of simply living with it and monitoring activity. Those diagnosed with more aggressive forms of the disease will find that is not the case for them. This more aggressive prostate cancer is known to resist standard courses of treatment and has perplexed doctors thus far.

The UC Santa Cruz researchers believe they may have uncovered just why this form of the disease is so persistent. It seems the cells found in metastasized prostate cancer patients have properties that are very similar to actual stem cells. To reveal that finding, researchers analyzed biopsies from men living with the disease at present. They found the signature between prostate stem cells and the aggressive prostate cancer was quite similar. While far from a cure just yet, the new research provides valuable insight into the nature of aggressive prostate cancer. It serves as a springboard for future studies to develop treatments that might prove more beneficial for those in later stages of the disease.

Early detection and treatment of prostate cancer is generally considered critical. While researchers strive for better treatments for advanced cases, men can help themselves by going in for routine exams. Men should begin talking to their healthcare providers about prostate health in their 40s or so.

# data[].attributes.attachment_link.title
Researchers Unlocking the Mystery of Late-Stage Prostate Cancer Cells

# data[].attributes.attachment_link.description
While most of the 220,000 American males diagnosed with prostate cancer this year will find their disease is in an earlier, more treatable stage, some will not. Aggressive forms of the disease, those that are later in stage and may have already spread to other parts of the body, pose a unique challenge in fighting.

# data[].attributes.body
While there’s no simple answer to the question, men will find they can work with their doctors to create a more individualized approach. The blood test in question is called the prostate-specific antigen test.

# data[].attributes.attachment_link.readable_text
There's a battle of opinions waging in the medical community that has men older men (and their doctors) confused on just how to proceed with prostate cancer screening. A simple blood test, once the gold standard for early detection, has been taken off the recommendation table as of late. A replacement, however, hasn't yet been found, leading many to wonder just how to effectively screen for this cancer that is the second leading cause of cancer-related deaths for American men.

While there's no simple answer to the question, men will find they can work with their doctors to create a more individualized approach. The blood test in question is called the prostate-specific antigen test. This tests looks for a specific protein in blood that may signal the presence of prostate cancer. The problem is that this protein may also have other causes, giving rise to false positives that ultimately lead to invasive biopsies that aren't always necessary.

It's a conundrum to be sure. Doctors on one side of the aisle want to spare their patients from unnecessary further testing by taking the PSA off the table for all but higher-risk cases. Doctors on the other side worry that cases that do develop in low-risk men are now going undetected and untreated. Formal recommendations have changed to remove the PSA from the routine for low-risk patients. Some doctors continue to recommend the test anyway.So, what's a man to do?

The best bet is to work directly with a healthcare provider to gauge individual risk. Screenings, including the PSA test, will generally begin in the 40s for men who are at higher risk, such as those with a family history of prostate cancer. For men in a low risk category, screening should begin around the age of 50. If prostate cancer is a concern, the PSA can still be given in lower risk cases. The decision to proceed should be made between a man and his doctor.

# data[].attributes.attachment_link.title
Sorting Through the Prostate Cancer Screening Controversy

# data[].attributes.attachment_link.description
There's a battle of opinions waging in the medical community that has men older men (and their doctors) confused on just how to proceed with prostate cancer screening. A simple blood test, once the gold standard for early detection, has been taken off the recommendation table as of late.

# data[].attributes.body
Antiandrogen drugs are sometimes used to help treat prostate cancer that is considered aggressive and has spread. This form of therapy is intended to assist controlling the disease or slowing its progression by essentially starving cancer cells of the fuel they use to grow.

# data[].attributes.attachment_link.readable_text
For men with asymptomatic or mildly symptomatic metastatic castration -resistant prostate cancer, one antiandrogen drug may work better than a more commonly prescribed option. Research is finding that the drug Enzalutamide performs better than bicalutamide in helping promote progression free survival.

Antiandrogen drugs are sometimes used to help treat prostate cancer that is considered aggressive and has spread. This form of therapy is intended to assist controlling the disease or slowing its progression by essentially starving cancer cells of the fuel they use to grow. Prostate cancer feeds off of androgen. By effectively blocking it, more serious forms of the disease can be tackled more readily to prolong life.

The latest research into the effectiveness of Enzalutamide is showing a great deal of promise. Men who were given this drug instead of bicalutamide in a double-blind trial were found, over all, to have a greater than 10-month improvement in survival without progression. While some side effects, such as fatigue, were more common with Enzalutamide, the enhanced survival potential was significant, researchers say. While the findings indicate a superior benefit from Enzalutamide use, researchers are looking into other questions the study raised. The big one is a desire to find out if there is a survival advantage to taking bicalutamide first and then Enzalutamide. How soon that study will be completed remains unclear.

Prostate cancer strikes an estimated 180,000 American men each year. While many men find their form of the disease is rather slow growing and requires little intervention, this is not always the case. For those with metastatic tumors, treatments are often required to prolong life. Antiandrogen therapy may be one of the best options. While bicalutamide has been used for some time to assist in this situation, Enzalutmide may offer a slight survival edge. Men who are diagnosed with prostate cancer are urged to discuss all treatment options with their healthcare providers.

# data[].attributes.attachment_link.title
Prostate Cancer Antiandrogen Therapy: Enzalutamide Offers Strong Results - Prostate Seed Institute

# data[].attributes.attachment_link.description
For men with asymptomatic or mildly symptomatic metastatic castration -resistant prostate cancer, one antiandrogen drug may work better than a more commonly prescribed option. Research is finding that the drug Enzalutamide performs better than bicalutamide in helping promote progression free survival. Antiandrogen drugs are sometimes used to help treat prostate cancer that is considered aggressive ...

# data[].attributes.body
A recent study looked at the differences between “favorable” and “unfavorable” cases. Nearly 1,600 men were included in the study.

# data[].attributes.attachment_link.readable_text
While many of the 180,000 American men diagnosed with prostate cancer in the upcoming year will find their disease is slow-growing and poses little risk, this isn't always the case. For men with intermediate risk forms of prostate cancer, radical prostatectomies may be necessary to improve survival chances. This doesn't mean, however, that all men who undergo this surgery will enjoy progression free survival in the future.

Researchers are finding that intermediate-risk prostate cancer does vary in prognosis based on a few factors. Cancers that are considered "favorable intermediate risk" are likely to have a significantly higher five-year recurrence free survival rate following prostate removal. Those with unfavorable forms of the disease are much more likely to see a recurrence.

A recent study looked at the differences between "favorable" and "unfavorable" cases. Nearly 1,600 men were included in the study. The two groups were identified by differences in their biopsies and Gleason scores, among other factors. When all was said and done, the overall prognosis for men in the "favorable" group was higher. Whether additional interventions might improve the rate of progression-free survival was not looked at. While further study is likely required to better understand the differences and how they impact prognosis, the research sheds light on the subtle differences in intermediate prostate cancer and the need to delve further into treatment options for those with "unfavorable" forms of the disease.

Prostate cancer is among the most commonly diagnosed forms of cancer among men in the United States. This condition, if caught early, can often be successfully addressed through a variety of treatment options. All men are technically at risk for this disease as they age. To find out more about personal prostate cancer risks, men should speak directly to their healthcare providers. Risk factors, such as family history, lifestyle and ethnicity, may increase the likelihood that this condition will develop.

# data[].attributes.attachment_link.title
Classifying Intermediate-Risk Prostate Cancer May Help Improve Outcomes - Prostate Seed Institute

# data[].attributes.attachment_link.description
While many of the 180,000 American men diagnosed with prostate cancer in the upcoming year will find their disease is slow-growing and poses little risk, this isn't always the case. For men with intermediate risk forms of prostate cancer, radical prostatectomies may be necessary to improve survival chances.

# data[].attributes.body
During the course of the study, researchers found that men who reached sexual maturity earlier were more likely to develop prostate cancer.

# data[].attributes.attachment_link.readable_text
Boys who enter puberty at younger ages might be at higher risk for developing prostate cancer down the road. That finding came from a recent study that looked at genetic data related to nearly 3,000 men. Some of the men in the study had prostate cancer and others did not.

During the course of the study, researchers found that men who reached sexual maturity earlier were more likely to develop prostate cancer. While the reason behind the finding are not fully understood, it is believed that longer exposure to growth hormones might be to blame. Researchers also found that boys who matured at later ages not only had lower overall risks, but also lower risks for more aggressive forms of the disease.

While much more research needs to be done to better understand the role early maturity may play, the initial findings offer a new path for clinicians to explore. This path may one day lead to a greater understanding of prostate cancer and actions that might help prevent it or at least lower risks. At present, the findings may indicate that boys who mature earlier may need to take extra steps to lower other risk factors for the disease. Healthy lifestyle choices, for example, could be especially important for those who mature early.

Prostate cancer strikes an estimated 180,000 American men each year. The disease is responsible for about 26,000 American deaths annually. All men are technically at risk for the formation of this disease as they age. Addressing risk factors, such as diet, obesity and chemical exposure, may help lower a man's risk.

Since prostate cancer can strike any man, it is recommended men begin undergoing routine screening for the disease around the age of 50. Men should, however, discuss their risk factors with their doctors sooner. Early detection of this disease can greatly increase the chances of successful treatment.

# data[].attributes.attachment_link.title
Early Puberty Can Increase Prostate Cancer Risk - Prostate Seed Institute

# data[].attributes.attachment_link.description
Boys who enter puberty at younger ages might be at higher risk for developing prostate cancer down the road. That finding came from a recent study that looked at genetic data related to nearly 3,000 men. Some of the men in the study had prostate cancer and others did not.

# data[].attributes.body
There are a number of factors that can make one man more likely to develop prostate cancer than another. Here we can discuss about six of them

# data[].attributes.attachment_link.readable_text
Prostate cancer affects about 180,000 American men each year. Often highly treatable, this disease is frequently beaten by those who manage to detect it early and undergo any treatments deemed necessary for saving lives. An estimated 26,000 American men, however, do die from the disease each year. That makes it especially important for men to understand not only the importance of early screening, but also their personal risk factors.

There are a number of factors that can make one man more likely to develop prostate cancer than another. Here are six of them:

Heredity - Inherited gene mutations are linked to the development of prostate cancer. These mutations are found in about 5 to 10 percent of all prostate cancers. That means family history of the disease is important to note.

Acquired gene mutations - Gene mutations can occur at different points in a man's life. These may be caused by environmental concerns, such as chemical exposure.

Age - Men who are over the age of 50 are more likely to develop prostate cancer than younger men. In fact, about 65 percent of all prostate cancer cases are diagnosed in men over the age of 65.

Ethnicity - African-American men are more likely to develop prostate cancer than their Caucasian counterparts. Asian men are known to have the lowest incident rate.

Sex - The fact of the matter is all men are at risk for developing prostate cancer. American men, however, are more likely than men from other parts of the world.

Lifestyle - Lifestyle issues, such as smoking, lack of exercise and a poor diet may all contribute to the development of prostate cancer. Obesity isn't directly linked to the disease's development, but it can play a role in more aggressive forms developing.

Men are encouraged to talk openly with their doctors about prostate cancer. This disease is estimated to strike about 1 in 7 American men over the course of their lifetimes.

# data[].attributes.attachment_link.title
6 Prostate Cancer Risk Factors All Men Should Know - Prostate Seed Institute

# data[].attributes.attachment_link.description
Prostate cancer affects about 180,000 American men each year. Often highly treatable, this disease is frequently beaten by those who manage to detect it early and undergo any treatments deemed necessary for saving lives. An estimated 26,000 American men, however, do die from the disease each year.

# data[].attributes.body
Researchers have found that lycopene can lower men’s prostate-specific antigen numbers and may also lower their risks of developing prostate cancer itself.

# data[].attributes.attachment_link.readable_text
The best way to beat prostate cancer is to prevent it in the first place. While this isn't always possible, there are measures men can take to lower their risks of developing this disease. One of the steps men can take to potentially lower their risks is to incorporate more "red foods" in their diet. Specifically, foods containing lycopene have been shown to have possible preventative effects.

Researchers have found that lycopene can lower men's prostate-specific antigen numbers and may also lower their risks of developing prostate cancer itself. Lycopene is found naturally in a number of foods that are considered part of a healthy, balanced diet. The highest lycopene-containing foods include tomatoes, apricots, watermelons and guavas. Some studies have also indicated that lycopene taken in supplement form may also have similar effects in lowering PSA levels.

An estimated 180,000 American men will be diagnosed with prostate cancer this year alone. It is estimated that 26,000 American men die from the disease annually. Men will find that risk factors for the disease include age, ethnicity, family history and certain lifestyle issues, such as poor diet and lack of exercise. All men, however, are technically at risk for the development of prostate cancer. With that in mind, it is recommended that men understand the risks and take steps that may help lower them.

Prostate cancer when caught early is often highly treatable. Men will find treatment options range from surveillance to complete removal of the prostate gland itself. Routine screening starting around the age of 50 or so can lead to early detection and treatment, if necessary. Men are encouraged to speak with their healthcare providers about their prostate cancer risks and when routine screening should begin in their cases. In the meantime, they can help prevent the disease by incorporating healthy diets, exercise and smart lifestyle choices into their daily routines.

# data[].attributes.attachment_link.title
Red Foods May Lower Prostate Cancer Risk - Prostate Seed Institute

# data[].attributes.attachment_link.description
The best way to beat prostate cancer is to prevent it in the first place. While this isn't always possible, there are measures men can take to lower their risks of developing this disease. One of the steps men can take to potentially lower their risks is to incorporate more "red foods" in their diet.

# data[].attributes.headline
Long-Term Hormone Therapy Can Help Prostate Cancer Patients

# data[].attributes.subject
Long-Term Hormone Therapy Can Help Prostate Cancer Patients

# data[].attributes.body
To arrive at that conclusion, researchers used data collected from 721 different patients. The research showed that radiotherapy dramatically reduced relapse rates in men who underwent this additional step of treatment.

# data[].attributes.attachment_link.readable_text
Giving men with locally advanced prostate cancer a more promising outlook may call for the use of an extended round of androgen deprivation therapy (ADT) after radiotherapy, researchers say. This commonly used hormone treatment has proven itself much more effective when an extended course of treatment is offered.

Those findings come from a study conducted by the Radiation Therapy Oncology Group. Researchers found over a 20-year study period that long-term ADT had strong impacts on improving the disease-free survival rate for men as opposed to shorter doses of treatment following radiation. At a median follow up range of 20 years, researchers found the disease-free survival rate for men with long-term therapy was 16 percent versus 10 percent for those only given shorter courses.

ADT is commonly used in the treatment of more advanced or aggressive cases of prostate cancer. The therapy, however, is often given for shorter periods of time after the use of radiation to help kill off cancer cells. Long-term ADT is defined as a dosing that lasts for at least two years following radiation therapy.

Hormone therapy is considered an important part of the care routine in many forms of cancer. When measures such as ADT are taken, the therapy helps starve cancer cells from the nutrition they need to survive. This extra layer of protection can help ensure that stray cancer cells potentially left behind after radiation do not have the ability to thrive.

Men who are diagnosed with prostate cancer should carefully discuss all treatment options with their healthcare providers. ADT is not recommended in all forms of prostate cancer. Its use is generally restricted to men with more advanced cases of the disease. The best treatment options for a patient will depend greatly on the particulars of the case in question.

# data[].attributes.attachment_link.title
Long-Term Hormone Therapy Can Help Prostate Cancer Patients

# data[].attributes.attachment_link.description
Giving men with locally advanced prostate cancer a more promising outlook may call for the use of an extended round of androgen deprivation therapy (ADT) after radiotherapy, researchers say. This commonly used hormone treatment has proven itself much more effective when an extended course of treatment is offered.

# data[].attributes.headline
  Procedure
  To Make the PSA More Reliable - Prostate Seed Institute

# data[].attributes.subject
  Procedure
  To Make the PSA More Reliable - Prostate Seed Institute

# data[].attributes.body
The United States Preventative Services Task Force no longer recommends the PSA test’s routine usage.

# data[].attributes.attachment_link.readable_text
The prostate-specific antigen blood test has long been used as the gold standard for detecting prostate cancer. Its high false positive rate, however, has led to this often lifesaving tool being taken off the table for routine screening. As some healthcare providers worry this change in screening recommendations may give rise to a higher rate undetected cancers going untreated, researchers in Canada have found a way to increase the reliability of PSA results.

The simple procedure being recommended by researchers in Ottawa involves nothing more than a repeat test. Their study has found that repeating the PSA before taking any action can reduce the amount of unnecessary biopsies performed by as much as 60 percent.

To arrive at those findings, researchers reviewed the records of 1,268 men who tested with an abnormally high PSA result. In 25 percent of these men, a second test returned with a normal result. About 28 percent of the men with conflicting results underwent biopsies compared with 62 percent of men who presented with two abnormal tests. Researchers also found that only 3 percent of men who had conflicting test results were diagnosed with cancer within a year as compared to 19 percent who had two abnormal test results.

The PSA offers great insights into the possible presence of prostate cancer. The test, however, isn't without its faults. PSA results can rise due to error in the laboratory, a man's physical activity level and even due to infections. When a single test is used to direct actions, false positives may lead to unnecessary, invasive procedures for men who find they do not have prostate cancer at all. The second test, researchers say, can be very important for helping obtain a more accurate gauge before further action is taken.

Men who are age 50 and older are urged to discuss prostate cancer screening with their healthcare providers. An estimated 220,000 American men are diagnosed with this disease every year. While the PSA is no longer used for routine screenings, the test is still available and, as researchers in Canada found out, can offer valuable insights.

# data[].attributes.attachment_link.title
Simple Procedure Can Make the PSA More Reliable

# data[].attributes.attachment_link.description
The prostate-specific antigen blood test has long been used as the gold standard for detecting prostate cancer. Its high false positive rate, however, has led to this often lifesaving tool being taken off the table for routine screening.

# data[].attributes.headline
Myths Behind Testosterone Therapy - Prostate Seed Institute

# data[].attributes.subject
Myths Behind Testosterone Therapy - Prostate Seed Institute

# data[].attributes.body
A recent study into the topic of prostate cancer information shed light on just how widespread the lack of information happens to be.

# data[].attributes.attachment_link.readable_text
Aging takes its toll on a man's body. Natural testosterone production goes down and the risk for prostate cancer rises. While testosterone replacement therapy can stave off some of the effects of aging, many fear this intervention could actually increase the likelihood of high-grade prostate cancer development. A recently released study, however, is offering a ray of hope to men who require long-term testosterone replacement therapy to keep them feeling better. The study found that when testosterone replacement therapy is used for up to 5 years, it is not associated with a greater risk for higher grade prostate cancer.

The study, recently published in the Journal of Urology, focused on more than 50,000 men with prostate cancer. In the study group, 574 men had used testosterone in the five years prior to diagnosis. The rate of high-grade prostate cancer diagnosis was 20.1 percent in the testosterone group and 27 percent in the men who did not undergo testosterone therapy. The results, researchers say, indicate that testosterone therapy may not pose the risk over the long-term that was once believed. Further study will be needed to help better guide treatments in the future.

An estimated 220,000 American men are diagnosed with prostate cancer each year. Commonly associated with aging, this disease is often highly treatable when it is detected early. Men who are over the age of 50 are urged to speak with their healthcare providers about screening for prostate cancer.

The use of hormone replacement therapy as men age is also an issue to discuss carefully with a healthcare provider. In some cases, this form of therapy can be very beneficial for helping men combat effects of aging, such as a loss of energy and libido. The best recommendation for a particular patient, however, will hinge on all medical facts in each unique case.

# data[].attributes.attachment_link.title
Testosterone Therapy Doesn't Increase High-Grade Prostate Cancer Risks

# data[].attributes.attachment_link.description
Aging takes its toll on a man's body. Natural testosterone production goes down and the risk for prostate cancer rises. While testosterone replacement therapy can stave off some of the effects of aging, many fear this intervention could actually increase the likelihood of high-grade prostate cancer development.

# data[].attributes.headline
  Risk
  Factors and Prevention About Prostate Cancer - Prostate Seed Institute

# data[].attributes.subject
  Risk
  Factors and Prevention About Prostate Cancer - Prostate Seed Institute

# data[].attributes.body
Those findings, researchers say, support the idea that delaying radiation provides no real benefit. What’s more, many other studies have shown that earlier radiation tends to be more effective. The best treatment recommendation will come from a doctor with knowledge of a man’s particular case.

# data[].attributes.attachment_link.readable_text
Obesity has been directly linked to the development of a wide variety of diseases, including certain forms of cancer. While being overweight won't necessarily cause prostate cancer to form, studies have found obesity may play a very strong role in the development of more aggressive forms of the disease.

Since the link between obesity and deadlier forms of prostate cancer has been found, researchers have been working to better understand just why that is. As it turns out, fat may actually fuel the growth of prostate cancer while promoting its spread. Some studies have indicated that the protein fat cells secrete is responsible for attracting tumor cells and aiding in their spread beyond the prostate itself. While many forms of prostate cancer are relatively easy to treat and may not even require medical intervention, aggressive forms of the disease are responsible for an estimated 30,000 deaths in America each year.

Approximately 200,000 American males are diagnosed with prostate cancer yearly. This disease has a number of risk factors, many which cannot be controlled. Obesity itself may not play a role in the actual development of the disease, but it can increase risks of death and complication. With that in mind, men who are obese or are nearing obese status are urged to take steps to reverse the condition. Eating smaller, balanced meals and exercising can make a big difference. If shedding pounds becomes difficult, doctors can offer assistance on this front.

Prostate cancer is considered a highly treatable disease in many cases. Men who are obese, however, may not find that to be the case for them. Taking action to control weight can help improve overall health while lowering risks for a wide variety of diseases. To learn more about prostate cancer, treatment and prevention, men should discuss the topic with their healthcare providers.

# data[].attributes.attachment_link.title
Fat and Prostate Cancer: A Dangerous Combination

# data[].attributes.attachment_link.description
Obesity has been directly linked to the development of a wide variety of diseases, including certain forms of cancer. While being overweight won't necessarily cause prostate cancer to form, studies have found obesity may play a very strong role in the development of more aggressive forms of the disease.

# data[].attributes.headline
  Going
  Vegan Could Help Prevent Prostate Cancer - Prostate Seed Institute

# data[].attributes.subject
  Going
  Vegan Could Help Prevent Prostate Cancer - Prostate Seed Institute

# data[].attributes.body
Researchers found that regular aspirin use may lower the likelihood of morbidity associated with prostate cancer. Men who had been diagnosed with prostate cancer that also took aspirin regularly were shown to have a 39 percent lower risk of dying from the disease than other patients.

# data[].attributes.attachment_link.readable_text
Men hoping to cut their risk of developing prostate cancer may find one of the more effective ways to do that is by adopting a vegan diet. That's according to a recent study that showed prostate cancer risks dropped rather nicely in men who employed this quite strict eating routine in their daily lives.

To arrive at the findings, researchers analyzed nearly 27,000 men who participated in a study to see if diet could play a role. Men in the study included groups that eat meat, some meat, dairy and eggs, but no meat, fish only and true vegans. When all was said and done, the vegan group showed statistically significant protective associations against prostate cancer risk. Other recent studies have backed up the vegan findings by showing a link between meat and prostate cancer.

Men interested in adopting a vegan diet will find the routine is simple, but not necessarily easy to stick with at first. The diet involves fruits, vegetables and grains with no meat and no dairy products. Egg and milk substitutes are used in place of these often necessary meal ingredients.

Prostate cancer strikes an estimated 200,000 American men each year. Approximately 30,000 American males die from this disease annually. While early detection and intervention can produce positive results, avoidance is the preferred route for many men. Risk factors for the disease include many items that men simply cannot control - including just being a man. Diet, however, is one aspect that can be changed. A vegan routine may offer help on this front. For those who cannot adhere to such a strict eating routine, a healthy, well-balanced diet that is rich in vegetables and fruits can also be a wise choice.

Men who are age 50 and above are urged to discuss their prostate cancer risks with their healthcare providers. Routine screening is generally recommended as men age to enable early detection of this disease should it present.

# data[].attributes.attachment_link.title
Vegan Diet May Lower Prostate Cancer Risks

# data[].attributes.attachment_link.description
Men hoping to cut their risk of developing prostate cancer may find one of the more effective ways to do that is by adopting a vegan diet. That's according to a recent study that showed prostate cancer risks dropped rather nicely in men who employed this quite strict eating routine in their daily lives.

# data[].attributes.headline
Yoga May Help Prostate Cancer Patients Cope - Prostate Seed Institute

# data[].attributes.subject
Yoga May Help Prostate Cancer Patients Cope - Prostate Seed Institute

# data[].attributes.body
There researchers found that yoga can help reduce stress and fatigue while increasing strength to the pelvic floor while boosting blood flow.

# data[].attributes.attachment_link.readable_text
No matter how it's cracked, undergoing radiation therapy to treat prostate cancer can take its toll on men and their quality of life. Even if no side effects from this potentially life-saving treatment present, the reality is the process can increase anxiety and drain men of energy. Researchers are finding, however, that yoga may help men combat some of the issues they face during treatment.

The study connecting yoga to better overall quality of life during radiation therapy comes courtesy of Penn's Abramson Cancer Center. There researchers found that yoga can help reduce stress and fatigue while increasing strength to the pelvic floor while boosting blood flow.

The study involved 45 cancer patients who agreed to attend twice-weekly yoga classes that last about 75 minutes each. Most of the men in the study reported an elevated sense of well-being after each class. Many also saw their fatigue decrease, along with other potential side effects of treatment. Some of the patients even requested information for creating their own at-home routines following the class.

An estimated 220,000 American men are diagnosed with prostate cancer each year. While this disease is often considered low-risk and slow growing, some men find that immediate intervention is required. Gland removal and the use of radiation are common treatments for helping men beat this disease. Having access to tools to ease the stress associated with treatment can greatly enhance a man's quality of life while facing prostate cancer.

Men who are diagnosed with prostate cancer are urged to discuss all treatment options with their healthcare providers. Should radiation or other forms of treatment be recommended, it can also be beneficial to talk about steps that can make the process easier. For some men, it seems, yoga offers a healthy, viable alternative for raising quality of life during and after treatment.

# data[].attributes.attachment_link.title
Yoga May Help Prostate Cancer Patients Cope - Prostate Seed Institute

# data[].attributes.attachment_link.description
No matter how it's cracked, undergoing radiation therapy to treat prostate cancer can take its toll on men and their quality of life. Even if no side effects from this potentially life-saving treatment present, the reality is the process can increase anxiety and drain men of energy.

# data[].attributes.headline
  Long-Term
  Hormone Therapy Can Help Prostate Cancer Patients

# data[].attributes.subject
  Long-Term
  Hormone Therapy Can Help Prostate Cancer Patients

# data[].attributes.body
ADT is not recommended in all forms of prostate cancer. Its use is generally restricted to men with more advanced cases of the disease.

# data[].attributes.attachment_link.readable_text
Giving men with locally advanced prostate cancer a more promising outlook may call for the use of an extended round of androgen deprivation therapy (ADT) after radiotherapy, researchers say. This commonly used hormone treatment has proven itself much more effective when an extended course of treatment is offered.

Those findings come from a study conducted by the Radiation Therapy Oncology Group. Researchers found over a 20-year study period that long-term ADT had strong impacts on improving the disease-free survival rate for men as opposed to shorter doses of treatment following radiation. At a median follow up range of 20 years, researchers found the disease-free survival rate for men with long-term therapy was 16 percent versus 10 percent for those only given shorter courses.

ADT is commonly used in the treatment of more advanced or aggressive cases of prostate cancer. The therapy, however, is often given for shorter periods of time after the use of radiation to help kill off cancer cells. Long-term ADT is defined as a dosing that lasts for at least two years following radiation therapy.

Hormone therapy is considered an important part of the care routine in many forms of cancer. When measures such as ADT are taken, the therapy helps starve cancer cells from the nutrition they need to survive. This extra layer of protection can help ensure that stray cancer cells potentially left behind after radiation do not have the ability to thrive.

Men who are diagnosed with prostate cancer should carefully discuss all treatment options with their healthcare providers. ADT is not recommended in all forms of prostate cancer. Its use is generally restricted to men with more advanced cases of the disease. The best treatment options for a patient will depend greatly on the particulars of the case in question.

# data[].attributes.attachment_link.title
Long-Term Hormone Therapy Can Help Prostate Cancer Patients

# data[].attributes.attachment_link.description
Giving men with locally advanced prostate cancer a more promising outlook may call for the use of an extended round of androgen deprivation therapy (ADT) after radiotherapy, researchers say. This commonly used hormone treatment has proven itself much more effective when an extended course of treatment is offered.

# data[].attributes.headline
Procedure To Make the PSA More Reliable - Prostate Seed Institute

# data[].attributes.subject
Procedure To Make the PSA More Reliable - Prostate Seed Institute

# data[].attributes.body
While the PSA is no longer used for routine screenings, the test is still available and, as researchers in Canada found out, can offer valuable insights.

# data[].attributes.attachment_link.readable_text
The prostate-specific antigen blood test has long been used as the gold standard for detecting prostate cancer. Its high false positive rate, however, has led to this often lifesaving tool being taken off the table for routine screening. As some healthcare providers worry this change in screening recommendations may give rise to a higher rate undetected cancers going untreated, researchers in Canada have found a way to increase the reliability of PSA results.

The simple procedure being recommended by researchers in Ottawa involves nothing more than a repeat test. Their study has found that repeating the PSA before taking any action can reduce the amount of unnecessary biopsies performed by as much as 60 percent.

To arrive at those findings, researchers reviewed the records of 1,268 men who tested with an abnormally high PSA result. In 25 percent of these men, a second test returned with a normal result. About 28 percent of the men with conflicting results underwent biopsies compared with 62 percent of men who presented with two abnormal tests. Researchers also found that only 3 percent of men who had conflicting test results were diagnosed with cancer within a year as compared to 19 percent who had two abnormal test results.

The PSA offers great insights into the possible presence of prostate cancer. The test, however, isn't without its faults. PSA results can rise due to error in the laboratory, a man's physical activity level and even due to infections. When a single test is used to direct actions, false positives may lead to unnecessary, invasive procedures for men who find they do not have prostate cancer at all. The second test, researchers say, can be very important for helping obtain a more accurate gauge before further action is taken.

Men who are age 50 and older are urged to discuss prostate cancer screening with their healthcare providers. An estimated 220,000 American men are diagnosed with this disease every year. While the PSA is no longer used for routine screenings, the test is still available and, as researchers in Canada found out, can offer valuable insights.

# data[].attributes.attachment_link.title
Simple Procedure Can Make the PSA More Reliable

# data[].attributes.attachment_link.description
The prostate-specific antigen blood test has long been used as the gold standard for detecting prostate cancer. Its high false positive rate, however, has led to this often lifesaving tool being taken off the table for routine screening.

# data[].attributes.headline
Myths Behind Testosterone Therapy - Prostate Seed Institute

# data[].attributes.subject
Myths Behind Testosterone Therapy - Prostate Seed Institute

# data[].attributes.body
The study, recently published in the Journal of Urology, focused on more than 50,000 men with prostate cancer. In the study group, 574 men had used testosterone in the five years prior to diagnosis.

# data[].attributes.attachment_link.readable_text
Aging takes its toll on a man's body. Natural testosterone production goes down and the risk for prostate cancer rises. While testosterone replacement therapy can stave off some of the effects of aging, many fear this intervention could actually increase the likelihood of high-grade prostate cancer development. A recently released study, however, is offering a ray of hope to men who require long-term testosterone replacement therapy to keep them feeling better. The study found that when testosterone replacement therapy is used for up to 5 years, it is not associated with a greater risk for higher grade prostate cancer.

The study, recently published in the Journal of Urology, focused on more than 50,000 men with prostate cancer. In the study group, 574 men had used testosterone in the five years prior to diagnosis. The rate of high-grade prostate cancer diagnosis was 20.1 percent in the testosterone group and 27 percent in the men who did not undergo testosterone therapy. The results, researchers say, indicate that testosterone therapy may not pose the risk over the long-term that was once believed. Further study will be needed to help better guide treatments in the future.

An estimated 220,000 American men are diagnosed with prostate cancer each year. Commonly associated with aging, this disease is often highly treatable when it is detected early. Men who are over the age of 50 are urged to speak with their healthcare providers about screening for prostate cancer.

The use of hormone replacement therapy as men age is also an issue to discuss carefully with a healthcare provider. In some cases, this form of therapy can be very beneficial for helping men combat effects of aging, such as a loss of energy and libido. The best recommendation for a particular patient, however, will hinge on all medical facts in each unique case.

# data[].attributes.attachment_link.title
Testosterone Therapy Doesn't Increase High-Grade Prostate Cancer Risks

# data[].attributes.attachment_link.description
Aging takes its toll on a man's body. Natural testosterone production goes down and the risk for prostate cancer rises. While testosterone replacement therapy can stave off some of the effects of aging, many fear this intervention could actually increase the likelihood of high-grade prostate cancer development.

# data[].attributes.headline
Risk Factors and Prevention About Prostate Cancer - Prostate Seed Institute

# data[].attributes.subject
Risk Factors and Prevention About Prostate Cancer - Prostate Seed Institute

# data[].attributes.body
Prostate cancer is considered a highly treatable disease in many cases. To learn more about prostate cancer, treatment and prevention, men should discuss the topic with their healthcare providers.

# data[].attributes.attachment_link.readable_text
Obesity has been directly linked to the development of a wide variety of diseases, including certain forms of cancer. While being overweight won't necessarily cause prostate cancer to form, studies have found obesity may play a very strong role in the development of more aggressive forms of the disease.

Since the link between obesity and deadlier forms of prostate cancer has been found, researchers have been working to better understand just why that is. As it turns out, fat may actually fuel the growth of prostate cancer while promoting its spread. Some studies have indicated that the protein fat cells secrete is responsible for attracting tumor cells and aiding in their spread beyond the prostate itself. While many forms of prostate cancer are relatively easy to treat and may not even require medical intervention, aggressive forms of the disease are responsible for an estimated 30,000 deaths in America each year.

Approximately 200,000 American males are diagnosed with prostate cancer yearly. This disease has a number of risk factors, many which cannot be controlled. Obesity itself may not play a role in the actual development of the disease, but it can increase risks of death and complication. With that in mind, men who are obese or are nearing obese status are urged to take steps to reverse the condition. Eating smaller, balanced meals and exercising can make a big difference. If shedding pounds becomes difficult, doctors can offer assistance on this front.

Prostate cancer is considered a highly treatable disease in many cases. Men who are obese, however, may not find that to be the case for them. Taking action to control weight can help improve overall health while lowering risks for a wide variety of diseases. To learn more about prostate cancer, treatment and prevention, men should discuss the topic with their healthcare providers.

# data[].attributes.attachment_link.title
Fat and Prostate Cancer: A Dangerous Combination

# data[].attributes.attachment_link.description
Obesity has been directly linked to the development of a wide variety of diseases, including certain forms of cancer. While being overweight won't necessarily cause prostate cancer to form, studies have found obesity may play a very strong role in the development of more aggressive forms of the disease.

# data[].attributes.headline
  Going
  Vegan Could Help Prevent Prostate Cancer - Prostate Seed Institute

# data[].attributes.subject
  Going
  Vegan Could Help Prevent Prostate Cancer - Prostate Seed Institute

# data[].attributes.body
Vegan diets can help reduce the risk of developing prostate cancer. A healthy, well-balanced diet that is rich in fruits and vegetables can also be a good choice.

# data[].attributes.attachment_link.readable_text
Men hoping to cut their risk of developing prostate cancer may find one of the more effective ways to do that is by adopting a vegan diet. That's according to a recent study that showed prostate cancer risks dropped rather nicely in men who employed this quite strict eating routine in their daily lives.

To arrive at the findings, researchers analyzed nearly 27,000 men who participated in a study to see if diet could play a role. Men in the study included groups that eat meat, some meat, dairy and eggs, but no meat, fish only and true vegans. When all was said and done, the vegan group showed statistically significant protective associations against prostate cancer risk. Other recent studies have backed up the vegan findings by showing a link between meat and prostate cancer.

Men interested in adopting a vegan diet will find the routine is simple, but not necessarily easy to stick with at first. The diet involves fruits, vegetables and grains with no meat and no dairy products. Egg and milk substitutes are used in place of these often necessary meal ingredients.

Prostate cancer strikes an estimated 200,000 American men each year. Approximately 30,000 American males die from this disease annually. While early detection and intervention can produce positive results, avoidance is the preferred route for many men. Risk factors for the disease include many items that men simply cannot control - including just being a man. Diet, however, is one aspect that can be changed. A vegan routine may offer help on this front. For those who cannot adhere to such a strict eating routine, a healthy, well-balanced diet that is rich in vegetables and fruits can also be a wise choice.

Men who are age 50 and above are urged to discuss their prostate cancer risks with their healthcare providers. Routine screening is generally recommended as men age to enable early detection of this disease should it present.

# data[].attributes.attachment_link.title
Vegan Diet May Lower Prostate Cancer Risks

# data[].attributes.attachment_link.description
Men hoping to cut their risk of developing prostate cancer may find one of the more effective ways to do that is by adopting a vegan diet. That's according to a recent study that showed prostate cancer risks dropped rather nicely in men who employed this quite strict eating routine in their daily lives.

# data[].attributes.headline
Exercise and Prostate Cancer: Do the Two Combine?

# data[].attributes.subject
Exercise and Prostate Cancer: Do the Two Combine?

# data[].attributes.body
Starting an exercise routine without medical clearance can be a dangerous proposition for some. It’s best to receive guidance first.

# data[].attributes.attachment_link.readable_text
As more studies uncover a link between the development of more aggressive forms of prostate cancer and obesity, researchers want to find out if exercise can make a difference. Whether getting physical can actually help slow the disease's progression and stop it from spreading remains to be seen. But, there are some who believe a real difference may be realized if men with the disease got up and got moving.

The study into the role exercise may play in helping keep the disease in check once it's presented is just now getting under way. Results won't be available for some time to come. In the meantime, men looking to lower their prostate cancer risks or help keep their bodies in the best shape possible after diagnosis may find these steps help:

Eat healthy -A well-balanced diet that's rich in fruits, vegetables, whole grains and lean proteins can help fuel the body to fight off all manner of diseases.

Avoiding tobacco use -Tobacco use, smoking especially, has been linked to a wide number of cancers. Kicking the habit can greatly reduce risks.

Keep weight in check -Obesity has been linked to a number of cancers. While it has not been definitively linked to the formation of prostate cancer, it is strongly linked to the spread of the disease and an increase in aggressiveness if it does form. Keeping weight in check can lower risks for a number of medical concerns.

Get active -While researchers are still looking into the benefits of regular aerobic exercise on controlling prostate cancer growth, getting physical in the meantime is still a great way to help keep the body healthy.

Men who want to take an active approach to preventing or treating prostate cancer should speak with their healthcare providers. Starting an exercise routine without medical clearance can be a dangerous proposition for some. It's best to receive guidance first.

# data[].attributes.attachment_link.title
Exercise and Prostate Cancer: Do the Two Combine? - Prostate Seed Institute

# data[].attributes.attachment_link.description
As more studies uncover a link between the development of more aggressive forms of prostate cancer and obesity, researchers want to find out if exercise can make a difference. Whether getting physical can actually help slow the disease's progression and stop it from spreading remains to be seen.